SunWay Biotech Co., LTD. (TPEX:1271)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
77.90
-0.40 (-0.51%)
Sep 4, 2025, 1:30 PM CST
-0.51%
Market Cap4.73B
Revenue (ttm)951.52M
Net Income (ttm)84.86M
Shares Out60.39M
EPS (ttm)1.40
PE Ratio55.88
Forward PEn/a
Dividend1.33 (1.82%)
Ex-Dividend DateJul 16, 2025
Volume91,122
Average Volume163,839
Open79.90
Previous Close78.30
Day's Range77.60 - 79.90
52-Week Range48.60 - 95.70
Beta-0.10
RSI56.97
Earnings DateAug 11, 2025

About SunWay Biotech Co., LTD.

SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan. [Read more]

Founded 2007
Employees 58
Stock Exchange Taipei Exchange
Ticker Symbol 1271
Full Company Profile

Financial Performance

In 2024, SunWay Biotech Co., LTD.'s revenue was 970.18 million, an increase of 69.88% compared to the previous year's 571.11 million. Earnings were 118.57 million, an increase of 157.26%.

Financial Statements

News

There is no news available yet.